NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.26
-0.59 (-1.65%)
At close: Dec 5, 2025, 4:00 PM EST
35.00
-0.26 (-0.74%)
After-hours: Dec 5, 2025, 6:50 PM EST
NAMS Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$45.80
Upside
+29.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +4.93% | Dec 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $44 | Buy | Maintains | $39 → $44 | +24.79% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $40 → $46 | Strong Buy | Maintains | $40 → $46 | +30.46% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $52 | Strong Buy | Initiates | $52 | +47.48% | Oct 20, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $42 → $50 | Strong Buy | Maintains | $42 → $50 | +41.80% | Oct 17, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $45 | Buy | Initiates | $45 | +27.62% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $38 → $39 | Buy | Maintains | $38 → $39 | +10.61% | Aug 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $27 | Hold | Initiates | $27 | -23.43% | Jul 17, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +19.12% | Jun 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +13.44% | Jun 12, 2025 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +24.79% | Jun 10, 2025 |
| Needham | Needham | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +13.44% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +19.12% | Apr 8, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +47.48% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Maintains $46 → $42 | Strong Buy | Maintains | $46 → $42 | +19.12% | Feb 27, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +13.44% | Jan 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.